APA (7th ed.) Citation
(2026). PLK1 overexpression as a dual-role biomarker and therapeutic vulnerability in pulmonary adenocarcinoma. PeerJ.
Chicago Style (17th ed.) Citation
"PLK1 Overexpression as a Dual-role Biomarker and Therapeutic Vulnerability in Pulmonary Adenocarcinoma." PeerJ 2026.
MLA (9th ed.) Citation
"PLK1 Overexpression as a Dual-role Biomarker and Therapeutic Vulnerability in Pulmonary Adenocarcinoma." PeerJ, 2026.
Warning: These citations may not always be 100% accurate.